Results 181 to 190 of about 58,085 (295)

Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients. [PDF]

Case Rep Dermatol, 2022
Balighi K, Heidari S, Kavyani M, Kamyab Hesari K, Tootoonchi N.   +4 more
europepmc   +1 more source

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial

Diabetes, obesity and metabolism, 2007
M. Nauck, G. Meininger, D. Sheng, L. Terranella, P. Stein   +4 more
semanticscholar   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

Circulation Journal, 2013
openaire   +3 more sources

Pharmacokinetics and Pharmacodynamics of Prusogliptin (DBPR108), a Once-Daily Dipeptidyl Peptidase-4 Inhibitor, in Patients with Type 2 Diabetes. [PDF]

Clin Pharmacokinet
Liu W, Yang K, Lin Y, Lu C, Liu J, Zhou H, Wang J, Zhang T, Yao L, Qi H, Zhang X, Jia R, Li X, Jing S.   +13 more
europepmc   +1 more source

Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. [PDF]

World J Diabetes, 2021
Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D.   +5 more
europepmc   +1 more source

Sodium glucose cotransporter-2-inhibitor dapagliflozin improves nonalcoholic fatty liver disease by ameliorating dipeptidyl-peptidase-4 protein expression in diabetic mice

, 2023
Dongming Zhao, Chengqiang Li, Yuman Sun, Jin-Yang Fan, Nan Wu, Yanan Sun, Xinyi Sun   +6 more
openalex   +1 more source

Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.

Cardiovascular Research, 2016
S. Takada, Yoshihiro Masaki, S. Kinugawa, J. Matsumoto, T. Furihata, Wataru Mizushima, Tomoyasu Kadoguchi, A. Fukushima, Tsuneaki Homma, Masashige Takahashi, S. Harashima, Shouji Matsushima, T. Yokota, S. Tanaka, K. Okita, H. Tsutsui   +15 more
semanticscholar   +1 more source

Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal. [PDF]

Molecules, 2022
Listos J, Listos P, Baranowska-Bosiacka I, Karpiuk A, Filarowska J, Łupina M, Słowik T, Zawiślak S, Kotlińska J.   +8 more
europepmc   +1 more source

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Diabetologia, 2006
I. Raz, M. Hanefeld, L. Xu, C. Caria, D. WILLIAMS-HERMAN, H. Khatami, Sitagliptin Study 023 Group   +6 more
semanticscholar   +1 more source

The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis. [PDF]

Neurocrit Care
Toker D, Chiang JN, Vespa PM, Schnakers C, Monti MM.   +4 more
europepmc   +1 more source